The ability to quantify, i.e. to estimate quantity, may provide evolutionary advantages in some contexts and has been demonstrated in a variety of animal species. In a prior study, we showed that angelfish (Pterophyllum scalare) were able to discriminate between groups (shoals) in which a large number of conspecifics swam preferring to join the larger of the two. Our results implied that angelfish can compare relative shoal sizes likely on the basis of some quantitative attributes of the shoal. Here, also using a binary preference test, we examined whether angelfish are able to discriminate between shoals of small numbers of conspecifics, and if so whether their performance reveals a comparable underlying mechanism to that proposed for discrimination of small quantities in human and non-human animals, namely the possible precursor of the ability to count. Our results demonstrate that fish reliably chose 4 versus 1, 3 versus 1, 2 versus 1 and 3 versus 2 individuals, but were at chance performance level when having to choose between 4 versus 3, 5 versus 4 and 6 versus 5. Findings also reveal that the density of the fish in the stimulus shoals did not significantly affect the performance of experimental angelfish. These results are compatible with the hypothesis of the existence of an object-file mechanism to discriminate small quantities in vertebrates and provide evidence for spontaneous discrimination of up to three elements in angelfish, a similar limit to that found in human and non-human animals. The findings add to the growing body of data, suggesting that the mechanisms underlying discrimination between different quantities of items may be shared across different taxa and have an evolutionary ancient origin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10071-011-0392-7 | DOI Listing |
Ecol Lett
January 2025
Estación Biológica de Doñana (EBD-CSIC), Sevilla, Spain.
With many species interacting in nature, determining which interactions describe community dynamics is nontrivial. By applying a computational modeling approach to an extensive field survey, we assessed the importance of interactions from plants (both inter- and intra-specific), pollinators and insect herbivores on plant performance (i.e.
View Article and Find Full Text PDFClin Cancer Res
January 2025
Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Purpose: Mesothelin (MSLN) is highly expressed in high grade serous/ endometrioid ovarian cancers (HGOC). Anetumab ravtansine (AR) is an antibody drug conjugate directed at MSLN antigen with a tubulin polymerization inhibitor. We assessed safety, activity and pharmacokinetics of the combination AR/bevacizumab (Bev) (ARB) versus weekly paclitaxel (wP)/Bev (PB) in patients with platinum resistant/refractory HGOC (prrHGOC).
View Article and Find Full Text PDFAm J Sports Med
January 2025
Department of Orthopaedic Surgery, Division of Physical Medicine and Rehabilitation, Stanford University, Stanford, California, USA.
Background: A bone stress injury (BSI) is a common overuse injury in collegiate athletes, particularly cross-country and track and field runners. Limited work describes the seasonality of BSIs or the differences in rates and anatomic locations of BSIs in collegiate runners.
Purpose: To describe seasonally related trends in anatomic locations of BSIs in National Collegiate Athletic Association (NCAA) Division I male and female middle- and long-distance runners.
Acta Ophthalmol
January 2025
Department of Ophthalmology, Faculty of Medicine, University of Cologne, Cologne, Germany.
Purpose: To analyse anterior segment optical coherence tomography (AS-OCT) parameters of graft dehiscence after Descemet membrane endothelial keratoplasty (DMEK) for graft failure post penetrating keratoplasty (PK).
Methods: Retrospective evaluation of AS-OCT images of 142 dehiscences post-DMEK in 75 eyes. Dehiscences' size, depth, location, correlation with graft-host interface (GHI) override and step at GHI were assessed.
Clin Cancer Res
January 2025
Istituti Fisioterapici Ospitalieri, Italy.
Background: The role of activating alterations in the MAPK pathway in predicting immunotherapy efficacy in lung squamous cell carcinoma (LSCC) patients is largely unknown. The aims of the randomized, phase II SQUINT trial were to assess the efficacy of nivolumab plus ipilimumab (NI) versus platinum-based chemotherapy plus nivolumab (N-CT) and to identify clinically available biomarkers of response to immunotherapy in patients with advanced or metastatic LSCC.
Methods: SQUINT was an open-label, randomized, parallel, non-comparative, phase II trial of NI versus N-CT in chemo-naïve, metastatic or recurrent LSCC adult patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!